4-EOTC,
4-epi-oxytetracycline,
4-epi-Oxytetracycline,
14206-58-7,
4-epioxytetracyline,
4-Epioxytetracycline,
UNII-73VON8SRY5,
73VON8SRY5,
2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,6,10,12,12a-hexahydroxy-6-methyl-1,11-dioxo-, (4R,4aR,5S,5aR,6S,12aS)-,
Hydroxy Quatrimycin,
(4R,4aR,5S,5aR,6S,12aS)-4-(dimethylamino)-3,5,6,10,12,12a-hexahydroxy-6-methyl-1,11-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide,
AC1O4BXW,
AC1MC55H,
Oxytetracycline dihydrate specified impurity A [EP],
Oxytetracycline hydrochloride specified impurity A [EP],
CTK8E8358,
ZINC4262012,
ZINC199067817,
(4R,4aR,5S,5aR,6S,12aS)-4-(Dimethylamino)-3,5,6,10,12,12a-hexahydroxy-6-methyl-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide,
BC298397,
TX-012036,
J-007590,
4-Epioxytetracycline, 'can be used as secondary standard',
(2Z,4R,4aR,5S,5aR,6S,12aS)-2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,6,10,11,12a-pentahydroxy-6-methyl-4,4a,5,5a-tetrahydrotetracene-1,3,12-trione,
(4R,4aR,5S,5aR,6S,12aS)-2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,6,10,11,12a-pentahydroxy-6-methyl-4,4a,5,5a-tetrahydrotetracene-1,3,12-trione,
(4R,4aR,5S,5aR,6S,12aS)-4-(Dimethylamino)-3,5,6,10,12,12a-hexahydroxy-6-methyl-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide (4-Epioxytetracycline),
[4R-(4|A,4a|A,5|A,5a|A,6|A,12a|A]-4-(Dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,6,10,12,12a-hexahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide,
Oxytetracycline (anhydrous),
CID2724548,
CID6364635,
CS-T-60108,
4-EPIOXYTETRACYCLINE, 'CAN BE USED AS SECONDARY STANDARD', 97,
2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,6,10,12,12a-hexahydroxy-6-methyl-1,11-dioxo-,[4R-(4.alpha.,4a.beta.,5.beta.,5a.beta.,6.alpha.,12a.beta.)]-,